The Effectiveness of Babadotan Leaves Aqueous Exctract and its Combination with Pregabalin as Anti Neuropathic-Pain and Acute Toxicity Testing
Abstract
Neuropathic pain is a condition that is difficult to treated and impaired quality of life. The objective of the study was to determine the anti-neuropathic pain effectivity of Ageratum conyzoides aqueous extract and the acute toxicity study. We had 7 groups (normal, negative, pregabalin, ageratum. conyzoides-I (AC-I) 50mg/kg BW, A. conyzoides-II (AC-II) 100mg/kg BW, combination of pregabalin and AC-II), combination of AC-II and naloxone). Each group contain 5 animals (mice). All groups was induced with pyridoxine 400 mg/kg BW i.p for 14 days to cause neuropathy and followed by hyperalgesia, allodynia, and wire-hang test. In the acute toxicity study, we had 1 group and contain 5 animals (rats). The results of the hyperalgesia and allodynia study showed the effect of AC-II was better than AC-I. The combination of pregabalin and AC-II was better than AC-II as monotherapy (p<0.05). However, AC II activity was abolished when combined with naloxone. In wire hang test demonstrated no difference between falling score (p: 0.053) and reaching score (0.903), that showed AC-II wasn’t impaired the motoric system. No death or toxicity symptoms were observed for 14 days in the acute toxicity study. A. conyzoides aqueous extract is potential for anti-neuropathic pain..
References
pain syndromes and defi nitions of pain terms. Pain. 1986. (suppl 3): S1–S225.
2. Brennan F, Carr DB, Cousins M. Pain management: a fundamental human right. Anesth Analg. 2007. 105:
205-21.
3. Sweetman SC. Martindale the complete drugs reference “thirty sixth edition”. London: Pharmaceutical Press.
2009. p. 2
4. O’Connor AB. Neuropathic pain: quality-of-life impact, costs and cost effectiveness of therapy.
PharmacoEconomics. 2009. 27(2): 95–112.
5. Cruccu G and Truini A. A review of neuropathic pain: from guidelines to clinical practice. Pain Ther. 2017.
6(Suppl 1): 35-42.
6. Taylor CP, Angelotti T, Fauman E. Pharmacology and mechanism of action of pregabalin: the calcium
channel alpha2-delta (alpha2-delta) subunit as a target for antiepileptic drug discovery. Epilepsy research.
2007. 73(2): 137–50.
7. Bamanikar A, Dhobale S, Lokwani S. Pregabalin hypersensitivity in a patient treated for postherpetic
neuralgia. Indian J Pharmacol. 2013. 45(5):522-3.
8. Mehta M, Shah J, Khakhkhar T, Shah R, Hemavathi KG. Anticonvulsant hypersensitivity syndrome
associated with carbamazepine administration: Case series. J Pharmacol Pharmacother. 2014. 5(1): 59-62.
9. Ono Y, Shimo T, Shirafuji Y, Hamada T, Masui M, Obata K, et al. Drug-induced hypersensitivity
syndrome caused by carbamazepine used for the treatment of trigeminal neuralgia. Case Rep Dent.
2016. 2016: 4605231.
10. Dharma AP. Indonesian Medicinal Plants [Tumbuhan Obat Indonesia]. Jakarta: Balai Pustaka; 1987.
11. BPOM RI. Ageratum conyzoides L. Direktorat obat asli Indonesia. 2008.
12. Singh SB, Devi WR, Marina A, Devi WI, Swapana N, Singh CB. Ethnobotany, phytochemistry and
pharmacology of Ageratum conyzoides Linn (Asteraceae). J.Med. Plant. Res. 2013. 7(8): 371-85.
13. Sukmawan, YP and Suhendy H. Hemostatic eff ect of ethanolic extract of Ageratum conyzoides l to strain
of mice male swiss webster induced with combination of aspirin, clopidogrel and enoxaparin. Asian J Pharm
Clin Res. 2017. 10(7): 276-9.
14. Suhendy Hand Sukmawan YP. Aktivitas immunomodulator ekstrak etanol daun babadotan
[Ageratum conyzoides (L.)] Terhadap mencit jantan galur swiss webster. Journal of Pharmacopolium. 2019.
2(1): 9-14.
15. Amadi BA, Duru MKC, Agomuo EN. Chemical profilesof leaf, stem, root and flower of Ageratum
conyzoides. Asian J. Plant Sci. Res. 2012. 2(4): 428-32.
16. Hasan MMd, Shahid-Ud-Daula AFM, Jahan IA, Nimmi I, Adnan T, Al-Mansur A, et al. Anti-inflammatory
activity, total flavonoids and tannin content from the ethanolic extract of Ageratum conyzoides linn. Leaf.
Int.J.Pharm. Phytopharmacol.Res. 2012. 1(5): 234-41.
17. Chauhan A and Rijhwani S. A Comprehensive review on phytochemistry of Ageratum conyzoides linn. (Goat
weed). Ijetmas. 2015. 3: 348-58.
18. Sukmawan, YP, Anggadiredja, K, Adnyana, IK. Antineuropathic pain activity of Ageratum conyzoides
L due to the essential oil components. CNS & neurological disorders drug targets. 2021. 20(2), 181–9.
19. Wang HY, Frankfurt M, Burns LH. High-affinity naloxone binding to fi lamin a prevents mu opioid
receptor-Gs coupling underlying opioid tolerance and dependence. PLoS One. 2008. 3(2): e1554.
20. Jordan MR, Morrisonponce D. Naloxone. In: StatPearls [serial online]. 2019 Jan. Diambil dari URL: https://
www.ncbi.nlm.nih.gov/books/NBK441910/. diakses 31 Mei, 2019.
21. Anjaneyulu M, Chopra K. Quercetin, a bioflavonoid, attenuates thermal hyperalgesia in a mouse model of
diabetic neuropathic pain. Prog Neuropsychopharmacol Biol Psychiatry. 2003. 27(6): 1001-5.
22. Gim H. Nam JH. Lee S. Shim JH. Kim HJ. Ha KT, et al. Quercetin inhibits pacemaker potentials via nitric
oxide/cGMP-dependent activation and trpm7/ano1 channels in cultured interstitial cells of cajal from
mouse small intestine. Cell Physiol Biochem. 2015. 35: 2422-43.
23. Parveen Z, Deng Y, Saeed MK, Dai R, Ahamad W, Yu YH. Antiinflammatory and analgesic activities
of Thesium chinense Turcz extracts and its major flavonoids, kaempferol and kaempferol-3-O-glucoside.
Yakugaku Zasshi. 2007. 127(8):1275-9.
24. Ogbru O. Lyrica Side Eff ects [serial online]. 2019 April. diambil dari URL: https://www.rxlist.com/lyrica-side-effects-drug-center.htm. diakses 31 Mei, 2019.
25. Çağlar Okur S, Vural M, Pekin Doğan Y, Mert M, Sayıner Çağlar N. The effect of pregabalin treatment
on balance and gait in patients with chronic low back pain: a retrospective observational study. J Drug
Assess. 2019. 8(1): 32-5.
26. Kalueff AV, Stewart AM, Song C, Berridge KC, Graybiel AM, Fentress JC. Neurobiology of rodent selfgrooming
and its value for translational neuroscience. Nat Rev Neurosci. 2016. 17(1): 45-59.
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Licencing
All articles in Jurnal Ilmu Kefarmasian Indonesia are an open-access article, distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License which permits unrestricted non-commercial used, distribution and reproduction in any medium.
This licence applies to Author(s) and Public Reader means that the users mays :
- SHARE:
copy and redistribute the article in any medium or format - ADAPT:
remix, transform, and build upon the article (eg.: to produce a new research work and, possibly, a new publication) - ALIKE:
If you remix, transform, or build upon the article, you must distribute your contributions under the same license as the original. - NO ADDITIONAL RESTRICTIONS:
You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
It does however mean that when you use it you must:
- ATTRIBUTION: You must give appropriate credit to both the Author(s) and the journal, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
You may not:
- NONCOMMERCIAL: You may not use the article for commercial purposes.
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Tools
